Biotechnology Companies By Pb Ratio
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Price To Book
| Price To Book | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | ACTU | Actuate Therapeutics, Common | 0.08 | 5.18 | 0.40 | ||
| 2 | PTCT | PTC Therapeutics | 0.11 | 3.11 | 0.33 | ||
| 3 | NEUP | Neuphoria Therapeutics | 0.15 | 6.70 | 1.01 | ||
| 4 | RGC | Regencell Bioscience Holdings | 0.04 | 17.14 | 0.69 | ||
| 5 | MBRX | Moleculin Biotech | 0.10 | 10.05 | 1.02 | ||
| 6 | OBIO | Orchestra BioMed Holdings | (0.03) | 4.61 | (0.12) | ||
| 7 | PLUR | Pluri Inc | (0.02) | 4.92 | (0.09) | ||
| 8 | ESLA | Estrella Immunopharma | 0.15 | 3.82 | 0.56 | ||
| 9 | ALNY | Alnylam Pharmaceuticals | 0.23 | 2.56 | 0.60 | ||
| 10 | RYTM | Rhythm Pharmaceuticals | 0.17 | 4.96 | 0.83 | ||
| 11 | MGTX | MeiraGTx Holdings PLC | 0.12 | 3.12 | 0.39 | ||
| 12 | LFCR | Lifecore Biomedical | (0.05) | 3.42 | (0.18) | ||
| 13 | AGEN | Agenus Inc | 0.01 | 6.49 | 0.09 | ||
| 14 | GALT | Galectin Therapeutics | 0.24 | 5.46 | 1.32 | ||
| 15 | OCGN | Ocugen Inc | 0.20 | 4.68 | 0.96 | ||
| 16 | INDV | Indivior PLC Ordinary | 0.31 | 2.71 | 0.83 | ||
| 17 | BBIO | BridgeBio Pharma | 0.09 | 2.53 | 0.23 | ||
| 18 | NNNN | Anbio Biotechnology Class | 0.06 | 6.57 | 0.41 | ||
| 19 | ANAB | AnaptysBio | 0.01 | 3.62 | 0.04 | ||
| 20 | CARM | Carisma Therapeutics | 0.01 | 14.37 | 0.14 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities. Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.